Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05346692 · ClinicalTrials.gov registry record · Early Phase 1
Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer
A Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, sponsored by Emory University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT05346692 is a Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm that has completed, run by Emory University. The registered enrollment target is 73 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05346692, a Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I trial tests a digital meditation for postoperative pain control after abdominal surgery for cancer. Mindfulness interventions such as guided meditation may improve pain control and decrease stress. Including a brief mindfulness intervention administered via test messages as part of postoperative care may improve pain severity, decrease opioid use, and improve patient responses to non-surgical treatments.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Interview
- OTHER Text Message-Based Navigation Intervention
Study Locations (1)
Georgia
- Emory University/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2023-07-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05346692
The ClinicalTrials.gov registry entry for NCT05346692 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (94% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT05346692 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05346692 about?
NCT05346692 is a clinical study titled "Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer". This phase I trial tests a digital meditation for postoperative pain control after abdominal surgery for cancer. Mindfulness interventions such as guided meditation may improve pain control and decrease stress. Including a brief mindfulness intervention administered via test messages as part of post...
What is the current status of trial NCT05346692?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 73 participants. The study started on 2022-03-28. Estimated completion is 2023-07-12.
What conditions does trial NCT05346692 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm.
What interventions are being tested in trial NCT05346692?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Text Message-Based Navigation Intervention (OTHER).
Who is sponsoring clinical trial NCT05346692?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05346692 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
RECRUITING · Early Phase 1
-
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
RECRUITING · Early Phase 1
-
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Malignant Solid Neoplasm
All registered trials for this condition
Hematopoietic and Lymphoid System Neoplasm
All registered trials for this condition
Georgia
All trials with a study site in Georgia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.